Prognia
Drug Database
🇺🇸US · FDA ApprovedNone (Tentative Approval)ANDA220238-002

ABEMACICLIB

Cyclin-dependent kinase (CDK) inhibitors

Manufacturer: QILU PHARMACEUTICAL CO., LTD.

FDA Approval: 06/11/2025

Active Ingredients

ABEMACICLIB 150MG

AI Drug & Interaction Analysis

Free account required

Ask Prognia AI about ABEMACICLIB — check interactions with your patient's full medication list, get dosing recommendations with renal/hepatic adjustments, and explore guideline-cited evidence.

Medical disclaimer: This drug information is intended for qualified healthcare professionals only. Always verify with the official FDA prescribing information before clinical use.